abstract |
The present invention relates to substituted quinoxaline-type bridged-piperidine compounds, compositions comprising an effective amount of substituted quinoxaline-type bridged-piperidine compounds, and methods for treating or preventing conditions such as pain, comprising adding to a patient in need thereof The animal is administered an effective amount of a substituted quinoxaline-type bridged-piperidine compound. |